Christopher B Cooper
Overview
Explore the profile of Christopher B Cooper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
229
Citations
3714
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaudhary M, Awan H, Gerard S, Bodduluri S, Comellas A, Barjaktarevic I, et al.
Am J Respir Crit Care Med
. 2025 Mar;
PMID: 40072247
Rationale: Quantifying functional small airways disease (fSAD) requires additional expiratory computed tomography (CT) scan, limiting clinical applicability. Artificial intelligence (AI) could enable fSAD quantification from chest CT scan at total...
2.
Barjaktarevic I, Hixson R, Zhuang Z, Buhr R, Tejwani V, Barr R, et al.
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40068143
Background: Reliable data about the natural history of lung function decline in alpha-1 antitrypsin (AAT) deficient Pi*MZ heterozygotes is largely missing. We hypothesized that, in adults with a tobacco smoking...
3.
Indoor Air Pollution, CT Airway-to-Lung Ratio and Lung Function Decline: Analyses from SPIROMICS AIR
Raju S, Woo H, Sack C, Hoffman E, Kaufman J, Barjaktarevic I, et al.
Am J Respir Crit Care Med
. 2025 Feb;
PMID: 40019825
No abstract available.
4.
Zhang X, Cooper C, Prince M, Ambale-Venkatesh B, Agarwal P, Backman M, et al.
Radiol Cardiothorac Imaging
. 2025 Jan;
7(1):e240053.
PMID: 39836055
Purpose To assess the repeatability of real-time cine pulmonary MRI measures of metronome-paced tachypnea (MPT)-induced dynamic hyperinflation and its relationship with chronic obstructive pulmonary disease (COPD) severity. Materials and Methods...
5.
Arjomandi M, Zeng S, Barjaktarevic I, Bleecker E, Bowler R, Criner G, et al.
Ann Am Thorac Soc
. 2024 Nov;
PMID: 39586032
Among tobacco-exposed persons with preserved spirometry (TEPS), we previously demonstrated that different lung volume indices, specifically elevated total lung capacity (TLC) versus elevated ratio of functional residual capacity-to-TLC (FRC/TLC), identify...
6.
Burnim M, Putcha N, LaFon D, Woo H, Azar A, Groenke L, et al.
Am J Respir Crit Care Med
. 2024 Oct;
211(2):215-221.
PMID: 39441116
Serum IgG deficiency is associated with morbidity in chronic obstructive pulmonary disease (COPD), but it is unclear whether concentrations in the lower end of the normal range still confer risk....
7.
Chaudhary M, Awan H, Gerard S, Bodduluri S, Comellas A, Barjaktarevic I, et al.
medRxiv
. 2024 Sep;
PMID: 39314974
Rationale: Quantifying functional small airways disease (fSAD) requires additional expiratory computed tomography (CT) scan, limiting clinical applicability. Artificial intelligence (AI) could enable fSAD quantification from chest CT scan at total...
8.
Wilkinson J, Wilhalme H, Cooper C, Barjaktarevic I, Tashkin D
Ann Am Thorac Soc
. 2024 Aug;
21(12):1706-1714.
PMID: 39163601
The slope of decline in forced expiratory volume in 1 second (FEV) is commonly used to reflect the rate of disease progression for descriptive studies and therapeutic trials in chronic...
9.
Curtis J, Bateman L, Murray S, Couper D, Labaki W, Freeman C, et al.
Chronic Obstr Pulm Dis
. 2024 Aug;
11(5):444-459.
PMID: 39159077
Background: The biological mechanisms leading some tobacco-exposed individuals to develop early-stage chronic obstructive pulmonary disease (COPD) are poorly understood. This knowledge gap hampers development of disease-modifying agents for this prevalent...
10.
Ruvuna L, Hijazi K, Guzman D, Guo C, Loureiro J, Khokhlovich E, et al.
medRxiv
. 2024 Aug;
PMID: 39148837
Rationale: Identification and validation of circulating biomarkers for lung function decline in COPD remains an unmet need. Objective: Identify prognostic and dynamic plasma protein biomarkers of COPD progression. Methods: We...